Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II trial of N-methylformamide for advanced renal cell carcinoma.

× No keyword cloud information.

6 in total

1. N-methylformamide affects spontaneous metastases of 3LL lines and increases natural killer activity of tumor-bearing mice.

Authors: C Greco; D Del Bufalo; D Giannarelli; M Marangolo; M P Fuggetta; E Bonmassar; G Zupi
Journal: Clin Exp Metastasis Date: 1990 Mar-Apr Impact factor: 5.150

2. Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.

Authors: G Arancia; C Leonetti; W Malorni; C Greco; G Formisano; M Marangolo; G Zupi
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

3. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.

Authors: W P McGuire; J A Blessing; K D Hatch; M L Berman
Journal: Invest New Drugs Date: 1990-05 Impact factor: 3.850

4. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group study.

Authors: W P McGuire; J A Blessing; J S Berek; A Munoz
Journal: Invest New Drugs Date: 1990-05 Impact factor: 3.850

5. Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.

Authors: E K Rowinsky; L B Grochow; A Hantel; D S Ettinger; B L Vito; R C Donehower
Journal: Invest New Drugs Date: 1989-11 Impact factor: 3.850

6. Phase II trial of N-methylformamide in patients with metastatic melanoma.

Authors: O Eton; D F Bajorin; E S Casper; A N Houghton
Journal: Invest New Drugs Date: 1991-02 Impact factor: 3.850

6 in total